NCT06622135View on ClinicalTrials.gov

Home Test for Measuring Plasma P-tau217 in Alzheimer's Disease

NATerminatedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

September 19, 2024

Primary Completion Date

December 7, 2024

Study Completion Date

December 7, 2024

Conditions
Alzheimer DiseaseHealthy Subjects
Interventions
DEVICE

Tasso Lancet Device

blood samples will be obtained from all participants using Tasso device

Trial Locations (2)

48507

Insight Research Institute, Flint

60616

Insight Research Institute/Insight Hospital and Medical Center Chicago, Chicago

Sponsors
All Listed Sponsors
lead

Insight Research Institute

OTHER